Read diazepam Results-at-a-Glance summary.
Diazepam is a medicine approved by the U.S. Food and Drug Administration (FDA) for treating severe seizures in children. However, the most safe and effective dosage of diazepam for children was unknown.
Read diazepam Results-at-a-Glance summary.
Diazepam is a medicine approved by the U.S. Food and Drug Administration (FDA) for treating severe seizures in children. However, the most safe and effective dosage of diazepam for children was unknown.
Read rifampin Results-at-a-Glance summary.
Rifampin is an FDA approved antibiotic but has not been evaluated for treating staph infection in infants. The purpose of the study was to find out the pharmacokinetics and safety of rifampin in infants with suspected infections.
Read levetiracetam Results-at-a-Glance summary.
Levetiracetam is a medicine that is approved by the U.S. Food and Drug Administration (FDA) for treating seizures in children. However, it is unknown how well the medicine works in children who weigh more than average. These studies were needed to learn how children who are heavier than average weight process levetiracetam and the amount of the medicine they should receive when being treated for seizures.
Read sildenafil Results-at-a-Glance summary.
Infants born too early can get a lung disease called Bronchopulmonary dysplasia (BPD). Infants with BPD are likely to have pulmonary hypertension, a condition where the blood vessels in the lungs get blocked or destroyed, causing high blood pressure. Pulmonary hypertension increases the risk of death from BPD. There are no medicines approved by the U.S. Food and Drug Administration (FDA) for treating BPD. However, doctors often use the medicine sildenafil to manage high blood pressure in infants with BPD.
Read oxycodone Results-at-a-Glance summary.
Oxycodone is a pain-relieving medicine often prescribed to mothers after giving birth. Studies have shown that oxycodone transfers into breastmilk, but data were lacking on how much of it is transferred to a breastfeeding infant. This information was needed for providers and mothers to make the best, safest decisions regarding medicines and breastfeeding. The Pediatric Trials Network (PTN) study called “Commonly Used Drugs During Lactation and Infant Exposure (CUDDLE)” tested medicines, including oxycodone, to learn how they transfer from mother to baby through breastmilk.
Read fluconazole Results-at-a-Glance summary.
Fluconazole is an antifungal medicine often used to treat and prevent yeast infections in infants born prematurely and full-term. In infants, yeast can cause serious infections all throughout the body, including the skin, blood, heart, eyes, and brain. These yeast infections occur because infants have weaker immune systems than older children and adults, and the infections can lead to long-term health issues or even death. Despite the frequent use of fluconazole in infants, there was little data available on the pharmacokinetics, or how the medicine is processed in infants’ bodies.
Watch the POP01 Results-at-a-Glance video summary.
This video version of the POP01 Results-at-a-Glance summary features iCAN member Poojasai.
Watch the metronidazole Results-at-a-Glance summary video.
This video version of the metronidazole Results-at-a-Glance summary features iCAN member Peter.
Watch the clindamycin Results-at-a-Glance summary video.
This video version of the clindamycin Results-at-a-Glance summary features iCAN member Hannah.
Read the 2023 PTN Annual Review.
This PTN Annual Review summarizes the Network’s activities in 2023.